Sun Pharmaceutical Industries

quarterly
yearly
ParticularsJun '21Sep '21Dec '21Mar '22Jun '22
Revenue9,7199,6269,8639,44710,762
Expenses8,1127,4507,80011,7608,611
EBITDA1,6072,1762,063-2,3132,151
EBIT1,1041,6461,510-2,8691,563
Profit Before Tax1,8042,2872,466-2,0762,285
Net Profit1,4442,0472,059-2,2772,061
Financial Ratios
Operating Profit Margin16.53%22.60%20.92%-24.48%19.98%
Net Profit Margin14.86%21.27%20.87%-24.11%19.15%
Earning Per Share (Diluted)8.058.508.601.188.60
Dividends Per ShareNA7.00NA3.00NA
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.3.6
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI